Aesthetic Medical International announced the closing of RMB100

SHENZHEN, China, July 13. 2022 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” Where “AIH”), a leading provider of aesthetic medical services in China, is pleased to announce that following its press release dated May 31, 2022, the Company has closed its previously announced private placement offering through the issuance of 21,413,276 ordinary shares of the Company (the “Subscription shares”) to Hawyu (HK) Limited at a price of RMB 4.67 per Subscription Share for aggregate gross proceeds of RMB 100 million (the “Offer”).

The net proceeds from the sale of Shares under the Offer are expected to be used by the Company for business expansion, working capital or other purposes, with the consent of the investors in accordance with the budget and the company’s approved business plan.

This press release does not constitute an offer to sell or the solicitation of an offer to buy such common stock, and there will be no sale of such common stock in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

The common shares sold under the private placement have not been registered under the Securities Act of 1933, as amended (the “Securities Law”), or the securities laws of any state or other applicable jurisdictions, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements of the Securities Act and the securities laws of any state or other applicable jurisdictions.

About Aesthetic Medical International Holdings Group Limited

AIH, known as “Peng’ai” in China, is one of the leading providers of aesthetic medical services in China. AIH operates through processing centers located in major cities in mainland China, with a particular focus on the Guangdong-Hong Kong-Macau Greater Bay Area and the Yangtze River Delta region. Backed by more than 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, general medical services and other aesthetic services. For more information about the company, please visit:


This press release contains “forward-looking statements”. These statements are made pursuant to the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by words such as “will”, “expect”, “anticipate” , “aims”, “future”, “intends”, “plans”, “believes”, “estimates”, “is likely to” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These and other risks and uncertainties relating to the Company’s business and financial condition are detailed from time to time in the Company’s filings with the SEC and could cause actual results to differ materially from those contained in any forward-looking statements. These forward-looking statements are made only as of the date indicated, and the Company undertakes no obligation to update or revise the information contained in the forward-looking statements, except as required by applicable law.

Investor Relations Contact Information

For investor and media inquiries, please contact:
International Medical Aesthetics Holdings Group Limited
Email: [email protected]

DLK Advisory Limited
Tel: +852 2857 7101
Email: [email protected]

Previous TIME Studios to begin production on two NFT-based series
Next Universal Credit Personal Loans Review 2022 - Forbes Advisor